## MAS: Masco Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -0.9% below STRENGTH zone (4.0-10.0%); PEG 1.50 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($61.07)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 1)

**1. Masco (NYSE:MAS) shareholders have earned a 9.9% CAGR over the last three years**
- Source: Simply Wall Street | 20260106T173817 | Neutral | Relevance: 99%
- Masco Corporation (NYSE:MAS) shareholders have seen a 26% share price increase over the last three years, which translates to a 9.9% Compound Annual Growth Rate (CAGR), but this underperforms the overall market return. While the share price has decreased by 11% in the last twelve months, the total shareholder return (TSR), which includes dividends, for the last three years is a more robust 33%. The company's EPS growth of 2.7% per year over the same period suggests that the market's opinion of Masco has improved.

**2. Masco (MAS): Buy, Sell, or Hold Post Q3 Earnings?**
- Source: Finviz | 20260105T230600 | Bearish | Relevance: 95%
- Masco (MAS) has underperformed the S&P 500, with a 1.9% loss against the S&P 500â€™s 10.1% gain over the last six months. Analysts express low confidence in Masco due to declining organic revenue, slim projected revenue growth, and decreasing return on invested capital (ROIC). Despite a fair valuation at 15.7x forward P/E, the stock's limited upside and potential downside lead experts to suggest exploring other investment opportunities.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Wells Fargo | $75 | $70 | +7% |
| 2025-12-08 | Barclays | $71 | $76 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Wells Fargo | up | Overweight |
| 2025-12-08 | Barclays | down | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.6% (-2.5%)
- Blackrock Inc.: 7.7% (-0.1%)
- JPMORGAN CHASE & CO: 4.9% (+164.5%)
- State Street Corpora: 4.9% (+3.8%)
- Harris Associates L.: 3.6% (+1.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.50 elevated, pricing in significant growth expectations. Forward P/E 15.3x stretched relative to 7% growth. Quality metrics strong (ROE 56%, ROA 15%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.5B |
| Beta | 1.28 |
| 52W Range | $56.55 - $82.18 |
| Short Interest | 4.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.50 |
| Forward P/E | 15.3 |
| Current P/E | 16.3 |
| YoY Growth | 7.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -0.9% (minimal 5-day change). Below STRENGTH zone by 4.9pp (needs >4.0% for momentum thesis). Below SMA200 (0.97x), long-term trend not supportive. RSI neutral at 50. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.92% (CS: 42) | Neutral |
| RSI_14 | 50.3 | Neutral |
| MACD Histogram | 0.04 | Bullish |
| vs SMA20 | 1.000x | Below |
| vs SMA50 | 1.012x | Above |
| vs SMA200 | 0.971x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $64.31
- **Stop Loss:** $61.07 (5.0% risk)
- **Target:** $67.55 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 231
- **Position Value:** $14,855.61
- **Portfolio %:** 14.86%
- **Risk Dollars:** $750.00
- **Risk Per Trade:** 0.75%
- **Modifiers:** L1 100% | L2 75% | Combined 0.75x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk appetite. VIX at 15.38 sits in the normal range (18th percentile of 52-week) with modest upward drift, while yield curve remains positively sloped (+62bps 10Y-3M) supporting risk assets. Breadth at 59.5% shows healthy participation, though elevated put/call ratio (1.12) suggests some hedging activity. FOMC 20 days out provides runway for current conditions to persist.*

### Earnings

**Next:** 2026-02-17 (Est: $0.79)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.03 | $0.97 | -5.7% |
| 2025Q2 | $1.08 | $1.30 | +20.7% |
| 2025Q1 | $0.91 | $0.87 | -4.8% |
| 2024Q4 | $0.87 | $0.89 | +1.9% |

---
*RULE-based L3 | 2026-01-08 08:02 | MRS_20*